UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 438,798 Shares of Schrodinger, Inc. $SDGR

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of Schrodinger, Inc. (NASDAQ:SDGR) by 16.5% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 2,221,485 shares of the company’s stock after selling 438,798 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Schrodinger were worth $36,099,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC lifted its position in Schrodinger by 722.8% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock worth $25,000 after buying an additional 1,207 shares in the last quarter. Los Angeles Capital Management LLC bought a new position in shares of Schrodinger in the 4th quarter valued at about $26,000. Hantz Financial Services Inc. increased its position in shares of Schrodinger by 5,025.8% in the fourth quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock valued at $28,000 after acquiring an additional 1,558 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake in shares of Schrodinger in the fourth quarter valued at about $36,000. Finally, State of Wyoming bought a new stake in Schrodinger during the second quarter worth about $39,000. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Wall Street Zen raised Schrodinger from a “strong sell” rating to a “hold” rating in a research report on Saturday, August 8th. UBS Group initiated coverage on Schrodinger in a research note on Friday, August 14th. They set a “neutral” rating and a $19.00 price objective on the stock. Weiss Ratings raised Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 27th. Finally, Morgan Stanley decreased their target price on shares of Schrodinger from $19.00 to $17.00 and set an “equal weight” rating for the company in a research note on Thursday, May 14th. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $20.50.

Schrodinger Stock Down 0.8%

Shares of NASDAQ SDGR opened at $20.71 on Friday. The business’s 50 day moving average price is $17.29 and its two-hundred day moving average price is $14.39. The company has a market cap of $1.53 billion, a PE ratio of -27.99 and a beta of 1.69. Schrodinger, Inc. has a twelve month low of $10.94 and a twelve month high of $23.02.

Schrodinger (NASDAQ:SDGR) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.49. The company had revenue of $58.89 million during the quarter, compared to analysts’ expectations of $47.19 million. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The business’s revenue was up 7.5% on a year-over-year basis. During the same period last year, the firm posted ($0.65) earnings per share. As a group, research analysts anticipate that Schrodinger, Inc. will post -1.89 EPS for the current fiscal year.

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.